-transparent.png){kind=logo}
Chemically modified anti-D typing serum is considered to combine the reliability of saline IgM anti-D with the convenience of slide and rapid tube anti-D. This has led to its wide acceptance in modern blood bank practice. False-positives are considered rare and are controlled by the ABO grouping. The extra step of an Rh control, which is necessary with IgG slide and rapid tube anti-D serums, is thus eliminated. However, this report shows that adopting this practice can be misleading and dangerous. Two cases are reviewed in which the chemically modified anti-D gave false-positive results and the ABO typing did not act as an adequate control.
Related Publications
E C Jones, and
M Sinclair, and
L Unrau, and
G Growe
January 1988,
Transfusion,
E C Jones, and
M Sinclair, and
L Unrau, and
G Growe
September 1995,
Journal of immunological methods,
E C Jones, and
M Sinclair, and
L Unrau, and
G Growe
July 1985,
The Medical journal of Australia,
E C Jones, and
M Sinclair, and
L Unrau, and
G Growe
December 2003,
Clinical and laboratory haematology,
E C Jones, and
M Sinclair, and
L Unrau, and
G Growe
February 1984,
Lancet (London, England),
E C Jones, and
M Sinclair, and
L Unrau, and
G Growe
October 1990,
Lancet (London, England),
E C Jones, and
M Sinclair, and
L Unrau, and
G Growe
January 1984,
Acta cytologica,
E C Jones, and
M Sinclair, and
L Unrau, and
G Growe
July 2010,
The British journal of psychiatry : the journal of mental science,
E C Jones, and
M Sinclair, and
L Unrau, and
G Growe
August 1986,
Lancet (London, England),
E C Jones, and
M Sinclair, and
L Unrau, and
G Growe
December 1987,
Clinical chemistry,
